Synergistic tumor inhibition of ZX-8177 in combination with anti-PD-L1 in MC38 syngeneic mouse model (TGI of anti-PD-L1 antibody vs. combo treatment is 53% vs. 75%) was observed as well. The gene discussed is CD274; the disease is neoplasm.